VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 163 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $268,000 | -2.9% | 13,892 | +28.3% | 0.00% | +50.0% |
| Q2 2022 | $276,000 | -39.2% | 10,824 | -0.2% | 0.00% | -33.3% |
| Q4 2021 | $454,000 | +189.2% | 10,846 | +201.3% | 0.00% | +200.0% |
| Q3 2021 | $157,000 | -18.7% | 3,600 | -11.6% | 0.00% | 0.0% |
| Q2 2021 | $193,000 | +35.0% | 4,074 | +46.0% | 0.00% | 0.0% |
| Q1 2021 | $143,000 | -22.7% | 2,790 | -59.7% | 0.00% | -50.0% |
| Q4 2020 | $185,000 | – | 6,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |